-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Manufacturers of specialty therapies aim to ensure patients can access, initiate, and remain on therapy while demonstrating clinical and economic value to payers, providers, and regulators. That means measuring time-to-therapy, initiation rates, prior-authorization success, adherence/persistence, patient support program (PSP) engagement, clinical outcomes, and downstream resource use — and linking those metrics to commercial and health-outcome
Dusting off my Pharmacy Analytics domain and starting to create some new content. I’m titling this one, “I’ve been taking data science classes so I can explain Generative AI”. I’m blending my love of frameworks and data science in one slide 😉
When I was asked to design an organization-wide customer experience (CX) improvement program, the most important lesson I learned wasn’t about which survey tool to use or which metric—NPS, CSAT, or CXi—was best. The real key was how you engage the organization and build momentum for change. A successful CX program isn’t a market research
Merilytic Health 